Stock WOCKPHARMA WOCKHARDT LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company Wockhardt Limited

Equities

WOCKPHARMA

INE049B01025

Pharmaceuticals

Market Closed - NSE India S.E.
Other stock markets
 09:03:24 2024-04-25 am EDT 		5-day change 1st Jan Change
570.6 INR +0.43% Intraday chart for Wockhardt Limited +4.28% +34.48%
Apr. 03 Wockhardt Limited Announces Cessation of Independent Directors CI
Feb. 14 Wockhardt Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI

Business Summary

Wockhardt Limited is a pharmaceutical and biotechnology company. The Company's businesses include manufacture and marketing of pharmaceutical and bio-pharmaceutical formulations, active pharmaceutical ingredients (APIs) and vaccines. It manufactures a range of dosage forms, including sterile injectables and lyophilized products. The Company offers products in therapeutic areas of dermatology, cosmeceuticals, oncology, medical nutrition, osteoarthritis, pain management, nephrology, cough therapy and diabetology. The Company’s products across India includes Citawok, Citawok Forte, Citawok Plus, CONSEGNA 30/70 U-200 CART, CONSEGNA R U-200 CART, DARBOTIN PFS, DECDAN, DECDAN B, DECDAN B Injection, DECDAN LITE CREAM, Emrok, Emrok O, Erliso, FOSCHEK-S, Gabawok NT, GLARITUS CART, GLARITUS DISPO, Glimaday, INOGLA, Livatira, GLARITUS CART and VAL 450. It has manufacturing and research facilities in India, United States of America and the United Kingdom and a manufacturing facility in Ireland.

Number of employees: 2,740

Sales per Business

INR in Million2022Weight2023Weight Delta
Pharmaceuticals
100.0 %
32,300 100.0 % 26,510 100.0 % -17.93%

Sales per region

INR in Million2022Weight2023Weight Delta
Europe
44.7 %
16,150 50.0 % 11,840 44.7 % -26.69%
India
23.0 %
6,610 20.5 % 6,090 23.0 % -7.87%
Rest of the World
20.9 %
6,120 18.9 % 5,550 20.9 % -9.31%
United States
11.4 %
3,420 10.6 % 3,030 11.4 % -11.40%

Managers

Managers TitleAgeSince
Murtaza Habil Khorakiwala CEO
 Chief Executive Officer 51 09-03-31
Habil Fakhruddin Khorakiwala FOU
 Founder 81 66-12-31
Deepak Madnani DFI
 Director of Finance/CFO - 22-02-28
Avijit Deb CTO
 Chief Tech/Sci/R&D Officer 76 -
Vijay Mhatre IRC
 Investor Relations Contact - -
Debolina Partap LAW
 General Counsel - -
Rashmi Mamtura SEC
 Corporate Secretary - 23-08-18

Members of the board

Members of the board TitleAgeSince
Habil Fakhruddin Khorakiwala FOU
 Founder 81 66-12-31
Akhilesh Krishna K. Gupta BRD
 Director/Board Member 71 20-08-28
Murtaza Habil Khorakiwala CEO
 Chief Executive Officer 51 09-03-31
Huzaifa Khorakiwala BRD
 Director/Board Member 53 96-06-30
Vinesh Kumar Madan Jairath BRD
 Director/Board Member 64 16-11-09
Zahabiya Khorakiwala BRD
 Director/Board Member - 17-10-29
Tasneem Zakaria Mehta BRD
 Director/Board Member - 14-09-29
Amelia Fernandes BRD
 Director/Board Member - 23-07-17

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 153,400,936 71,032,352 ( 46.31 %) 0 46.31 %

Shareholders

NameEquities%Valuation
Themisto Trustee Co. Pvt Ltd.
43.92 %
67,374,744 43.92 % 471 M ₹
Callirhoe Trustee Co., Pvt Ltd.
3.323 %
5,096,751 3.323 % 36 M ₹
Pasithee Trustee Co. Pvt Ltd.
3.305 %
5,070,000 3.305 % 35 M ₹
Ananke Trustee Co. Pvt Ltd.
2.891 %
4,434,530 2.891 % 31 M ₹
Rakesh Radheshyam Jhunjhunwala
1.913 %
2,935,005 1.913 % 21 M ₹
Mirae Asset Investment Managers (India) Pvt Ltd.
0.5674 %
870,406 0.5674 % 6 M ₹
Samco Asset Management Pvt. Ltd.
0.4322 %
663,000 0.4322 % 5 M ₹
Habil Fakhruddin Khorakiwala
0.3894 %
597,286 0.3894 % 4 M ₹
Invesco Asset Management (India) Pvt Ltd.
0.3783 %
580,270 0.3783 % 4 M ₹
Aditya Birla Sun Life Amc Ltd. (Investment Management)
0.3192 %
489,644 0.3192 % 3 M ₹

Company contact information

Wockhardt Ltd.

Wockhardt Towers Bandra Kurla Complex

400051, Mumbai

+91 24 0669 4444

http://www.wockhardt.com
address Wockhardt Limited(WOCKPHARMA)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Generic Pharmaceuticals

Sales per region

Sector Generic Pharmaceuticals

1st Jan change Capi.
WOCKHARDT LIMITED Stock Wockhardt Limited
+34.48% 1.05B
OTSUKA HOLDINGS CO., LTD. Stock Otsuka Holdings Co., Ltd.
+18.59% 22.25B
SANDOZ GROUP AG Stock Sandoz Group AG
+14.12% 14.39B
CIPLA LIMITED Stock Cipla Limited
+12.83% 13.55B
ZYDUS LIFESCIENCES LIMITED Stock Zydus Lifesciences Limited
+38.02% 11.27B
ONO PHARMACEUTICAL CO., LTD. Stock Ono Pharmaceutical Co., Ltd.
-9.80% 6.95B
THE MEDICINES COMPANY Stock The Medicines Company
-0.05% 6.79B
STADA ARZNEIMITTEL Stock STADA Arzneimittel
-8.87% 5.73B
ASPEN PHARMACARE HOLDINGS LIMITED Stock Aspen Pharmacare Holdings Limited
+6.29% 5.01B
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD. Stock Shenzhen Salubris Pharmaceuticals Co., Ltd.
-8.24% 4.51B
Generic Pharmaceuticals
  1. Stock Market
  2. Equities
  3. WOCKPHARMA Stock
  4. Company Wockhardt Limited